CONSUMER HEALTH IN CROATIA

Euromonitor International

January 2019

LIST OF CONTENTS AND TABLES

Executive Summary

Still Plenty of Space for Growth

General Improvement in the Economy Supports Sales of Consumer Health Products

Problems With Parent Company Do Not Bother Pliva Hrvatska

Liberalisation of the Market Still Just A Wish

the Future To Be Very Much Shaped by Legislation

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 2 Life Expectancy at Birth 2013-2018

Market Data

Table 3 Sales of Consumer Health by Category: Value 2013-2018

Table 4 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 5 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 6 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 7 Penetration of Private Label by Category: % Value 2013-2018

Table 8 Distribution of Consumer Health by Format: % Value 2013-2018

Table 9 Distribution of Consumer Health by Format and Category: % Value 2018

Table 10 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 1 Research Sources

Headlines

Prospects

Analgesics Consists of Three Main Formats

Idea of Liberalisation on Hold for Now

Paediatric Analgesics Still With Low Coverage

Competitive Landscape

A Local Company Leads the Field

Topical Analgesics/anaesthetic Strongly Led by Voltaren

Innovation Is Usually in the Direction of Combination Products

Category Data

Table 12 Sales of Analgesics by Category: Value 2013-2018

Table 13 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 15 NBO Company Shares of Analgesics: % Value 2014-2018

Table 16 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 17 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Headlines

Prospects

No Major Flu Outbreaks in the Winter of 2017/2018

Allergy Incidences Increase

Public Healthcare To Influence Future Sales

Competitive Landscape

Wide Product Portfolio Launches GlaxoSmithKline To the Top

Pgt Healthcare Is Second

Humble Contribution From Local Players

Category Data

Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 21 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 22 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Headlines

Prospects

Dermatologicals Not A Good Area for Non-prescription Medicine

Humble Reach of Paediatric Dermatologicals

Two Possible Trends for the Future

Competitive Landscape

Versatility of Bepanthen

Important Antifungals

Local Companies Almost Invisible

Category Data

Table 25 Sales of Dermatologicals by Category: Value 2013-2018

Table 26 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 27 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 28 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 29 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 30 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Headlines

Prospects

Indigestion Remains the Biggest Problem

Two Main Causes of Digestive Problems

Strong Competition From Prescription Medicines

Competitive Landscape

Known Global Brands Lead the Field

Locals Compete by Offering Some Traditional Solutions

Biggest Categories Left To Local and Regional Producers

Category Data

Table 31 Sales of Digestive Remedies by Category: Value 2013-2018

Table 32 Sales of Digestive Remedies by Category: % Value Growth 2013-2018

Table 33 NBO Company Shares of Digestive Remedies: % Value 2014-2018

Table 34 LBN Brand Shares of Digestive Remedies: % Value 2015-2018

Table 35 Forecast Sales of Digestive Remedies by Category: Value 2018-2023

Table 36 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023

Headlines

Prospects

A Great Deal of Scepticism Still About

Sports Protein Products Still Dominate

Widening the Target Group May Help the Industry

Competitive Landscape

Non-store Retailing Still the Main Channel

Only One Domestic Player of Note

Private Label With Limited Reach

Category Data

Table 37 Sales of Sports Nutrition by Category: Value 2013-2018

Table 38 Sales of Sports Nutrition by Category: % Value Growth 2013-2018

Table 39 NBO Company Shares of Sports Nutrition: % Value 2014-2018

Table 40 LBN Brand Shares of Sports Nutrition: % Value 2015-2018

Table 41 Forecast Sales of Sports Nutrition by Category: Value 2018-2023

Table 42 Forecast Sales of Sports Nutrition by Category: % Value Growth 2018-2023

Headlines

Prospects

Dietary Supplements the Orphan of Croatian Health

Standard Form Is Still Stronger Than Herbal

Dietary Supplements Are Convenient Replacements for A Healthy Diet

Competitive Landscape

Local Companies Dominate Dietary Supplements

Multinationals Quite Weak

Private Label Below Potential

Category Data

Table 43 Sales of Dietary Supplements by Category: Value 2013-2018

Table 44 Sales of Dietary Supplements by Category: % Value Growth 2013-2018

Table 45 Sales of Dietary Supplements by Positioning: % Value 2013-2018

Table 46 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2013-2018

Table 47 NBO Company Shares of Dietary Supplements: % Value 2014-2018

Table 48 LBN Brand Shares of Dietary Supplements: % Value 2015-2018

Table 49 Forecast Sales of Dietary Supplements by Category: Value 2018-2023

Table 50 Forecast Sales of Dietary Supplements by Category: % Value Growth 2018-2023

Headlines

Prospects

Institutions Frown Upon Unsubstantiated Claims

Multivitamins Have A Slight Lead in Terms of Format

Poor Nutrition and Stress Are the Main Drivers of Demand

Competitive Landscape

Strong Presence of Locals

Multinational Brands Produced on Location

Private Label Underperforming

Category Data

Table 51 Sales of Vitamins by Category: Value 2013-2018

Table 52 Sales of Vitamins by Category: % Value Growth 2013-2018

Table 53 Sales of Multivitamins by Positioning: % Value 2013-2018

Table 54 NBO Company Shares of Vitamins: % Value 2014-2018

Table 55 LBN Brand Shares of Vitamins: % Value 2015-2018

Table 56 Forecast Sales of Vitamins by Category: Value 2018-2023

Table 57 Forecast Sales of Vitamins by Category: % Value Growth 2018-2023

Headlines

Prospects

Slow Progress for Herbal/traditional Products

Consumer Impatience Works in Favour of Standard Products

Herbal/traditional Product Manufacturers on Good Terms With Official Bodies

Competitive Landscape

Very Fragmented Category

Locals Putting Up A Brave Fight

Private Label Struggles To Compete

Category Data

Table 58 Sales of Herbal/Traditional Products: Value 2013-2018

Table 59 Sales of Herbal/Traditional Products: % Value Growth 2013-2018

Table 60 NBO Company Shares of Herbal/Traditional Products: % Value 2014-2018

Table 61 LBN Brand Shares of Herbal/Traditional Products: % Value 2015-2018

Table 62 Forecast Sales of Herbal/Traditional Products: Value 2018-2023

Table 63 Forecast Sales of Herbal/Traditional Products: % Value Growth 2018-2023

Headlines

Prospects

Demographics Playing A Negative Role

Increasing Interest in Child-related Products

A Proactive Approach Still Far Away

Competitive Landscape

Brands Merely Extensions of Existing Lines

Paediatric and Herbal/traditional Still Quite Separate Areas

One Quite Successful Private Label

Category Data

Table 64 Sales of Paediatric Consumer Health by Category: Value 2013-2018

Table 65 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018

Table 66 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018

Table 67 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023

Table 68 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

The pharmaceuticals market in Croatia cannot be said to be small, but, as of 2018, it was still far from reaching its full potential. However, it is rigidly monitored, and limitations are set up so that most of the medication can only be purchased via prescription. Over the review period, sales of pharmaceuticals grew at a very slow rate. There are two forces at work that might come to the rescue for consumer health in Croatia: first is cutting down on costs, which has been forced on the Ministr...

Euromonitor International's Consumer Health in Croatia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.